Key Highlights

  • Shares are trading 24.35% higher at $8.56 on Thursday, October 29, 2026, from an implied prior close near $6.88 (calculated).
  • Third-quarter revenue was $605.1 million, down 3% from $626.4 million, close to the top of the $569 million to $609 million guided range.
  • Adjusted EBITDA grew 14% to $79.4 million, above the $62 million to $74 million guided range.
  • The net loss shrank to $26.9 million, or $0.15 a share, from $49.5 million, or $0.28.
  • Cash was $849.9 million at September 30, while convertible notes of $997.6 million are now classed as current.

Teladoc Stock Surge: What Pushed Shares 24.35% Higher After the Third-Quarter Report?

Teladoc Health (NYSE:TDOC) shares are trading 24.35% higher at $8.56 on Thursday, October 29, 2026. The company issued third-quarter results on Wednesday, October 28, 2026, and held its call that afternoon, which makes Thursday the first full session to respond.

Teladoc delivers virtual care through Integrated Care, which sells telehealth and chronic condition programmes to employers and health plans, and BetterHelp, an online therapy service sold to consumers and, increasingly, through insurance.

Revenue was $605.1 million, down 3% from $626.4 million. Management said revenue finished near the high end of guidance and adjusted EBITDA landed above the range.

Teladoc Segment Breakdown: Is Integrated Care Making Up for BetterHelp's Slide?

Integrated Care revenue grew 2% to $398.5 million, and its adjusted EBITDA increased 13% to $74.9 million, an 18.8% margin against 17.0%. Chronic Care enrollment hit 1.344 million, up 15%, while U.S. members eased 2% to 100.1 million.

BetterHelp revenue declined 13% to $206.6 million. Consumer and other revenue fell 25% to $174.5 million, partly cushioned by insurance covered services, which rose to $32.1 million from $3.7 million. Average paying users dropped 12% to 336,000.

BetterHelp adjusted EBITDA inched up to $4.5 million from $3.8 million. The release listed the cash-pay decline and a possible BetterHelp goodwill impairment among its risks.

Teladoc Earnings and Balance Sheet: How Far Did the Loss Shrink and What Does Debt Look Like?

Quarterly adjusted EBITDA was $79.4 million against $69.9 million. The net loss narrowed to $26.9 million, or $0.15 a share, from $49.5 million, or $0.28, a year earlier, when results included a $12.6 million goodwill impairment.

Operating cash flow grew 7% to $106.5 million and free cash flow increased 12% to $75.9 million.

Cash and equivalents totaled $849.9 million, up from $781.1 million at December 31, 2025. Convertible senior notes of $997.6 million are now classified as current, and the release gives neither their maturity nor their coupon. No buyback was disclosed.

Teladoc Outlook: Which Full-Year and Fourth-Quarter Ranges Moved?

Full-year revenue is now guided to $2.395 billion to $2.441 billion, compared with $2.362 billion to $2.447 billion in July. Adjusted EBITDA is guided to $277 million to $303 million, with the low end raised from $271 million, and free cash flow to $135 million to $165 million, a tighter band than $130 million to $170 million.

Fourth-quarter revenue is guided to $569 million to $615 million and adjusted EBITDA to $74 million to $100 million. BetterHelp revenue is expected to decline 18.5% to 31.5%.

What to Watch Next: Can BetterHelp Insurance Revenue Offset Cash-Pay Losses?

The chief executive said early partners are rolling out Teladoc One and that the steps taken are gaining traction, with more work ahead. The fourth-quarter report should show BetterHelp insurance volumes, provider capacity, Integrated Care member trends against the 99.5 million to 100.5 million guide, and more detail on the convertible notes due within a year.